cordycepin has been researched along with Osteoarthritis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashraf, S; Burston, JJ; Chapman, V; de Moor, CH; Gandhi, RD; Gowler, P; Piccinini, AM; Radhi, M; Thorn, GJ; Walsh, DA | 1 |
| Chen, H; Cheng, S; Peng, L; Shen, Y; Ying, X; Yu, K | 1 |
| Chen, P; Fan, S; Lei, C; Ma, J; Mei, S; Ning, L; Wang, J; Xia, C; Zhang, J | 1 |
3 other study(ies) available for cordycepin and Osteoarthritis
| Article | Year |
|---|---|
The polyadenylation inhibitor cordycepin reduces pain, inflammation and joint pathology in rodent models of osteoarthritis.
Topics: Animals; Arthritis, Experimental; Deoxyadenosines; Disease Models, Animal; Humans; Inflammation; Joints; Mice; NF-kappa B; Osteoarthritis; Pain; Polyadenylation; Rats; Signal Transduction | 2019 |
Cordycepin prevented IL-β-induced expression of inflammatory mediators in human osteoarthritis chondrocytes.
Topics: Aged; Anti-Inflammatory Agents; Chondrocytes; Deoxyadenosines; Female; Humans; Interleukin-1beta; Male; Middle Aged; Osteoarthritis | 2014 |
Photo-crosslinked HAMA hydrogel with cordycepin encapsulated chitosan microspheres for osteoarthritis treatment.
Topics: Animals; Antineoplastic Agents; Cartilage, Articular; Cell Survival; Chitosan; Chondrocytes; Deoxyadenosines; Drug Compounding; Drug Delivery Systems; Drug Liberation; Fluorescent Antibody Technique; Humans; Hyaluronic Acid; Hydrogel, Polyethylene Glycol Dimethacrylate; Immunohistochemistry; Male; Mice; Microspheres; Osteoarthritis | 2017 |